Rickets clinical trials at University of California Health
3 in progress, 1 open to eligible people
Showing trials for
ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 Deficiency
open to eligible people ages up to 1 year
The primary purpose of Study INZ701-104 (the ENERGY study) is to assess the safety and tolerability of INZ-701 in infants with ENPP1 Deficiency or with ABCC6 Deficiency.
at UCSD
First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Sorry, not currently recruiting here
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
at UCSF
X-linked Hypophosphatemia Disease Monitoring Program
Sorry, in progress, not accepting new patients
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.
at UCLA UCSF
Our lead scientists for Rickets research studies include Anthony Portale.
Last updated: